Redx Pharma PLC (GB:REDX)
LSE:REDX

Redx Pharma (REDX) Share Price & Analysis

1 Followers

REDX Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range26.50p - 70.00p
Previous Close28p
Volume58.00
Average Volume (3M)19.47K
Market Cap
£93.78M
Enterprise Value5.82B
Total Cash (Recent Filing)£53.85M
Total Debt (Recent Filing)£18.30M
Price to Earnings (P/E)-3.5
Beta-0.22
Dec 20, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding275,282,205
10 Day Avg. Volume46,462
30 Day Avg. Volume19,469
Standard Deviation0.46
R-Squared0.00657
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1731.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

REDX FAQ

What was Redx Pharma PLC’s price range in the past 12 months?
Redx Pharma PLC lowest share price was 26.50p and its highest was 70.00p in the past 12 months.
    What is Redx Pharma PLC’s market cap?
    Currently, no data Available
    When is Redx Pharma PLC’s upcoming earnings report date?
    Redx Pharma PLC’s upcoming earnings report date is Dec 20, 2023 which is in 198 days.
      How were Redx Pharma PLC’s earnings last quarter?
      Redx Pharma PLC released its earnings results on May 17, 2023. The company reported -0.062p earnings per share for the quarter, missing the consensus estimate of N/A by -0.062p.
        Is Redx Pharma PLC overvalued?
        According to Wall Street analysts Redx Pharma PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Redx Pharma PLC pay dividends?
          Redx Pharma PLC does not currently pay dividends.
          What is Redx Pharma PLC’s EPS estimate?
          Redx Pharma PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Redx Pharma PLC have?
          Redx Pharma PLC has 334,911,470 shares outstanding.
            What happened to Redx Pharma PLC’s price movement after its last earnings report?
            Redx Pharma PLC reported an EPS of -0.062p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.859%.
              Which hedge fund is a major shareholder of Redx Pharma PLC?
              Currently, no hedge funds are holding shares in GB:REDX

              ---

              Redx Pharma Stock Smart Score

              1
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -54.09%
              12-Months-Change

              Fundamentals

              Return on Equity
              -285.71%
              Trailing 12-Months
              Asset Growth
              7.28%
              Trailing 12-Months
              The Redx Pharma Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Redx Pharma PLC

              Redx Pharma PLC is a UK biotechnology company whose vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Hikma Pharmaceuticals
              Dechra Pharmaceuticals
              Indivior
              Verona Pharma
              Alliance Pharma

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis